Drug Shortage Report for MARCAINE E
| Report ID | 105225 |
| Drug Identification Number | 02241916 |
| Brand name | MARCAINE E |
| Common or Proper name | MARCAINE E |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPIVACAINE HYDROCHLORIDE EPINEPHRINE BITARTRATE |
| Strength(s) | 5.0MG 9.1MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | BLOCK/INFILTRATION EPIDURAL |
| Packaging size | 20mL GVL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-03 |
| Estimated end date | |
| Actual end date | 2020-08-24 |
| Shortage status | Resolved |
| Updated date | 2020-08-25 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.